{"id":1020956,"date":"2026-11-13T09:29:19","date_gmt":"2026-11-13T14:29:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/"},"modified":"2026-11-13T09:29:19","modified_gmt":"2026-11-13T14:29:19","slug":"lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/","title":{"rendered":"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>AlterG revenue increased 18% year-over-year to $3.6 million, driven by higher U.S. unit shipments, service revenue and average selling prices<\/em>\n      <\/p>\n<p align=\"center\">\n        <em>The Company is advancing its transition of ReWalk to a capital-efficient channel-partner distribution model designed to expand patient access and support long-term revenue growth<\/em>\n      <\/p>\n<p align=\"center\">\n        <em>New leadership team focused on commercial execution and advancing AI-enabled rehabilitation technologies<\/em>\n      <\/p>\n<p align=\"center\">\n        <em>New peer-reviewed clinical evidence strengthens support for ReWalk\u2019s long-term benefits and broader patient access<\/em>\n      <\/p>\n<p align=\"justify\">HUDSON, Mass. and YOKNEAM ILLIT, Israel, Nov.  13, 2026  (GLOBE NEWSWIRE) &#8212; Lifeward Ltd. (Nasdaq: LFWD) (\u201cLifeward\u201d or the \u201cCompany\u201d), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today reported financial results for the third quarter ended September 30, 2026, and provided a business update.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Business Update<\/u><br \/>\n        <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:3pt;margin-bottom:8pt;text-align:justify\">\n          <strong>Continued growth of AlterG.<\/strong> AlterG revenue increased 18% to $3.6 million in the third quarter of 2026 compared to the third quarter of 2025, primarily reflecting higher U.S. unit shipments, together with increased service revenue and improved average selling prices. This marks the second consecutive quarter of double-digit year-over-year revenue growth for AlterG.<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">\n          <strong>ReWalk commercial transition to a channel-partner model.<\/strong> The Company is shifting ReWalk from direct sales to partnerships with established home and durable medical equipment providers and patient care organizations that can bring the ReWalk Personal Exoskeleton to patients across the United States. These partnerships build on the Company\u2019s existing channels, including CorLife, its exclusive distributor for patients with workers\u2019 compensation claims, and the pilot program the Company launched in August 2026 with Ottobock Care, a leading U.S. mobility technology patient care organization with more than 50 patient clinics nationwide. While the transition has affected the timing of ReWalk sales in the near term, the Company believes channel partnerships have the potential to significantly increase ReWalk revenue over the long term and is focused on expanding its partner network. Selling through partners on wholesale terms is also designed to reduce the Company\u2019s operating expenses and may accelerate cash collection compared with direct sales.<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">\n          <strong>Broad reimbursement access supporting ReWalk adoption.<\/strong> ReWalk is covered by Medicare for eligible beneficiaries under an established fee schedule and by the three largest Medicare Advantage insurers, Aetna, Humana and UnitedHealthcare. Medicare Fee-for-Service and many national Medicare Advantage plans are authorizing ReWalk for clinically appropriate patients, and the Company believes this reimbursement infrastructure positions its channel partners to reach more eligible patients.<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">\n          <strong>Expansion of clinical evidence supporting ReWalk.<\/strong> In September and October 2026, the Company announced the publication of two peer-reviewed real-world studies of the ReWalk Personal Exoskeleton. The first reported improved performance of daily activities, higher satisfaction and lower pain compared with wheelchair use. The second, a long-term study, reported sustained home use over a median of 33 months with no reported falls or exoskeleton-related fractures.<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">\n          <strong>Well positioned for artificial intelligence (\u201cAI\u201d)-enabled rehabilitation.<\/strong> As robotics and AI increasingly move into physical care, the Company believes its combination of U.S. Food and Drug Administration (\u201cFDA\u201d)-cleared robotic products, established reimbursement infrastructure, commercial channels and installed base position it to bring AI-enabled rehabilitation technologies to patients. In addition to continued development of its upper-body exoskeleton with AI capabilities, Lifeward is exploring the addition of other AI-enabled capabilities into its product development pipeline.<\/li>\n<\/ul>\n<p align=\"justify\">\u201cThe third quarter was a transitional quarter for Lifeward, marked by continued AlterG growth as we move into the advanced stages of transitioning ReWalk to a channel-partner distribution model,\u201d said Josh Hexter, Interim Chief Executive Officer of Lifeward. \u201cMoving away from direct sales can create timing gaps in the near term, but we believe partnering with established providers that already reach patients nationwide is the right path to significantly expand access to ReWalk and accelerate revenue growth over the long term.\u201d<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Third Quarter 2026 Financial Results<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Revenue<\/strong> was $5.4 million in the third quarter of 2026, compared to $6.2 million in the third quarter of 2025, a decrease of $0.8 million, or 12%. Revenue from AlterG products and services increased 18% to $3.6 million, primarily reflecting higher U.S. unit shipments, together with increased service revenue and improved average selling prices. Revenue from the sale of ReWalk Personal exoskeletons was $1.7 million, compared to $3.0 million in the third quarter of 2025, reflecting lower U.S. sales as the Company transitions ReWalk to a channel-partner distribution model, as well as lower revenues in Europe.<\/p>\n<p align=\"justify\">\n        <strong>Gross margin<\/strong> was 27.4% during the third quarter of 2026, compared to 43.7% in the third quarter of 2025. The year-over-year decrease was primarily attributable to adverse foreign exchange rate fluctuations, higher freight costs and tariffs and revenue sharing expense arising from the Company\u2019s March 2026 acquisition of Oratech Pharmaceuticals Ltd. from Oramed Pharmaceuticals Inc. (the \u201cOratech Acquisition\u201d), under which the Company agreed to make quarterly payments to Oramed based on sales of ReWalk Personal Exoskeleton products and related extended warranties. On a non-GAAP basis, adjusted gross margin was 27.5% during the third quarter of 2026, compared to 43.7% in the prior-year quarter.<\/p>\n<p align=\"justify\">\n        <strong>Total operating expenses<\/strong> in the third quarter of 2026 were $7.5 million, compared to $5.9 million in the third quarter of 2025. The increase was primarily attributable to approximately $0.5 million of clinical trial and contract research organization service costs related to the Oratech clinical trial, higher development costs related to the AlterG product improvement project and the upper-body exoskeleton technology, higher spending on trade shows and digital marketing, and restructuring expenses. On a non-GAAP basis, which excludes the items listed in the attached non-GAAP reconciliation table, adjusted operating expenses were $7.0 million in the third quarter of 2026, compared to $5.7 million in the third quarter of 2025, with the year-over-year change primarily attributable to the Oratech clinical trial costs and product development activities.<\/p>\n<p align=\"justify\">\n        <strong>Operating loss<\/strong> in the third quarter of 2026 was $6.0 million, compared to $3.1 million in the third quarter of 2025. On a non-GAAP basis, which excludes the items in the attached non-GAAP reconciliation table, adjusted operating loss was $5.5 million in the third quarter of 2026, compared to $3.0 million in the third quarter of 2025.<\/p>\n<p align=\"justify\">\n        <strong>Net loss<\/strong> was $5.1 million, or $1.32 per share, in the third quarter of 2026, compared to $3.2 million, or $2.37 per share, in the third quarter of 2025. The increase primarily reflects a higher operating loss partially offset by net financial income of $0.9 million in the third quarter of 2026, which includes non-cash fair value changes in warrant and derivative liabilities as well as interest expense related to the Company\u2019s convertible notes. On a non-GAAP basis, which excludes the items in the attached non-GAAP reconciliation table, adjusted net loss was $5.5 million, or $1.44 per share, in the third quarter of 2026, compared to $3.0 million, or $2.24 per share, in the third quarter of 2025.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Balance Sheet<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Unrestricted cash and cash equivalents<\/strong> were $4.5 million as of September 30, 2026, compared to $2.2 million as of December 31, 2025.<\/p>\n<p align=\"justify\">\n        <strong>About Lifeward<\/strong>\n      <\/p>\n<p align=\"justify\">Lifeward is a global innovator focused on advancing medical technologies and biomedical solutions that improve lives. The Company\u2019s established portfolio includes market-leading neurorehabilitation technologies such as the ReWalk\u00ae Exoskeleton, AlterG\u00ae Anti-Gravity systems, and MyoCycle\u00ae FES System. These solutions span the continuum of care in physical rehabilitation and recovery, deploying the most advanced robotics and AI technologies to restore full health and quality of life to a broadening patient population. The Company is now executing a strategic evolution into a diversified biomedical company, expanding beyond rehabilitation and into high-value therapeutic platforms. This includes its Protein Oral Delivery (POD\u2122) platform, designed to enable oral delivery of biologic drugs, with lead candidate ORMD-0801 (oral insulin) targeting a large and underserved diabetes market.<\/p>\n<p align=\"justify\">Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UMDxuyUfArww2GmNZh4x7wH4OmrS8ISYUcADBghuxeHwc8q4UcGkGVvHoCpistaPm6BMfJ9pioMQTh93wJHB9g==\" rel=\"nofollow\" target=\"_blank\"><u>GoLifeward.com<\/u><\/a>.<\/p>\n<p align=\"justify\">Lifeward<sup>\u00ae<\/sup>, ReWalk<sup>\u00ae<\/sup>, ReStore<sup>\u00ae<\/sup> and Alter G<sup>\u00ae<\/sup> are registered trademarks of Lifeward Ltd. and\/or its affiliates.<\/p>\n<p>\n        <strong>Use of Non-GAAP Financial Measures<\/strong>\n      <\/p>\n<p align=\"justify\">In addition to financial results prepared in accordance with U.S. GAAP, this earnings release includes certain non-GAAP financial measures, including adjusted gross profit, adjusted gross margin, adjusted operating expenses, adjusted operating loss, adjusted net loss and adjusted net loss per share. These measures exclude certain items, as applicable, including stock-based compensation expense, restructuring expense, acquired in-process research and development expense, transaction-related expenses, amortization of acquired intangible assets, non-cash debt-discount amortization, changes in the fair value of warrant and derivative liabilities, acquisition-related income or expense and other items reflected in the reconciliations below.<\/p>\n<p align=\"justify\">Management believes the non-GAAP financial information provided in this release is useful to investors in understanding and assessing the Company\u2019s ongoing operations. Management uses both GAAP and non-GAAP information to evaluate and operate the business internally and believes it is useful to provide this information to investors. Non-GAAP financial measures should not be considered in isolation or as a substitute for, or superior to, financial measures prepared in accordance with U.S. GAAP. The GAAP results and reconciliations of the non-GAAP measures to the most directly comparable GAAP measures are provided below.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, and Section 21E of the U.S. Securities Exchange Act of 1934. Such forward-looking statements may include projections regarding the Company\u2019s future performance and other statements that are not statements of historical fact and, in some cases, may be identified by words like \u201canticipate,\u201d \u201cassume,\u201d \u201cbelieve,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cfuture,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201cseek\u201d and similar terms or phrases. For example, when the Company discusses the transition of ReWalk to a channel-partner distribution model and its potential to increase ReWalk revenue, the anticipated growth of AlterG, the development and potential benefits of AI-enabled capabilities and products, reimbursement coverage, the expected benefits of the channel-partner model, including the potential for lower operating expenses and faster cash collection, demand for rehabilitation technologies, and the Company\u2019s strategy, priorities and long-term growth, it is using forward-looking statements. The forward-looking statements contained in this press release are based on management\u2019s current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company\u2019s control. Important factors that could cause the Company\u2019s actual results to differ materially from those indicated in the forward-looking statements include, among others, risks and uncertainties relating to: the integration of Oratech and realization of the anticipated benefits of the Oratech acquisition; the development, timing, results and regulatory approval of ORMD-0801 and the Company\u2019s other product and clinical-development programs; the sufficiency of the Company\u2019s capital resources, its ability to obtain additional financing and continue as a going concern, and potential dilution resulting from its outstanding convertible securities and warrants; commercialization, market acceptance, reimbursement and sales growth for the Company\u2019s products; the Company\u2019s reliance on third-party payors, manufacturers, suppliers and distributors, and its customer and trade-receivables concentration; recent management and Board transitions; regulatory compliance, product defects and adverse events; intellectual-property protection; cybersecurity; and legislative, regulatory, political and economic developments, as well as other factors discussed under the heading \u201cRisk Factors\u201d in the Company\u2019s annual report on Form 10-K, for the year ended December 31, 2025, in Part II, Item 1A of the Company\u2019s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, and in other documents subsequently filed with, or furnished to, the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company\u2019s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.<\/p>\n<p align=\"justify\">\n        <strong>Contact<\/strong>\n      <\/p>\n<p>Ronen Tsimerman<br \/>Chief Financial Officer<br \/>Lifeward<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rIOVt92IQ4nWFgsoAdYj5_EtBfjudh5ckSovcapuPcodAMPub-30xDie3tlOse-aWxqDTMvY9Xac3ZV_yXbNerHLRZ8HHITFe-hMl1YqAu0=\" rel=\"nofollow\" target=\"_blank\"><u>media@golifeward.com<\/u><\/a><br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sJANWyf_V0q9NnhpqEohjqc491qaR8z3pANCBenOaP1UEkdt0CMT31aG3cFsAoRD2YsMc5hFmNW2fLGEYROqt2iN1xwm1aKMTFIUmgrbUNc=\" rel=\"nofollow\" target=\"_blank\"><u>ir@golifeward.com<\/u><\/a><\/p>\n<p>\u00a0\u00a0<strong>Lifeward Ltd. and subsidiaries<\/strong><\/p>\n<p>\n        \n      <\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>Condensed Consolidated Statements of Operations<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(Unaudited)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(In thousands, except share and per share data)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"6\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Three Months Ended<\/strong>\n          <\/td>\n<td colspan=\"6\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Nine Months Ended<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"6\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>September 30,<\/strong>\n          <\/td>\n<td colspan=\"6\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"3\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"3\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"3\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"3\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:52%;width:52%;min-width:52%;vertical-align: top\">Revenue<\/td>\n<td colspan=\"2\" style=\"max-width:11%;width:11%;min-width:11%;text-align: right;vertical-align: middle;vertical-align: top\">$5,428<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"max-width:11%;width:11%;min-width:11%;text-align: right;vertical-align: middle;vertical-align: top\">$6,195<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"max-width:11%;width:11%;min-width:11%;text-align: right;vertical-align: middle;vertical-align: top\">$15,974<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"max-width:11%;width:11%;min-width:11%;text-align: right;vertical-align: middle;vertical-align: top\">$16,953<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Cost of revenues<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">3,941<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">3,488<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">10,436<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">9,613<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Gross profit<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,487<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">2,707<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">5,538<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">7,340<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\" style=\"vertical-align: top\">Operating expenses:<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Research and development, net<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,941<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">721<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">9,540<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">2,406<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Sales and marketing<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">3,351<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">3,168<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">10,153<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">10,790<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">General and administrative<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">2,165<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,958<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">6,306<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">5,917<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Impairment charges<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">&#8211;<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">&#8211;<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">&#8211;<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">2,783<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Total operating expenses<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">7,457<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">5,847<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">25,999<\/td>\n<td>\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">21,896<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Operating loss<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(5,970<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(3,140<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(20,461<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(14,556<\/td>\n<td style=\"padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Financial expense (income), net<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">\u2007(926<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">23<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">6,879<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(8<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:51%;min-width:51%;vertical-align: top\">Loss before income taxes<\/td>\n<td colspan=\"2\" style=\"max-width:11%;min-width:11%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(5,044<\/td>\n<td style=\"max-width:1%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"max-width:11%;min-width:11%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(3,163<\/td>\n<td style=\"max-width:1%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"max-width:11%;min-width:11%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(27,340<\/td>\n<td style=\"max-width:1%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"max-width:1%;min-width:1%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(14,548<\/td>\n<td style=\"max-width:1%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Taxes on income<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">8<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">7<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">24<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">18<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Net loss<\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">$(5,052<\/td>\n<td style=\"border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">$(3,170<\/td>\n<td style=\"border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">$(27,364<\/td>\n<td style=\"border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">$(14,566<\/td>\n<td style=\"border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Basic net loss per ordinary share<\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">$(1.32<\/td>\n<td style=\"border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">$(2.37<\/td>\n<td style=\"border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">$(9.91<\/td>\n<td style=\"border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">$(13.87<\/td>\n<td style=\"border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Weighted average number of shares used in computing net loss per ordinary share basic and diluted (*)<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">3,836,950<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">1,335,117<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">2,760,466<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"border-top: solid black 1pt;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">1,050,290<\/td>\n<td style=\"border-bottom: solid black 1pt\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\">\n            <em>(*) All share and per share amounts presented in this note have been retroactively adjusted to reflect the Company\u2019s 1-for-12 reverse share split effected on February 24, 2026.<\/em>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"3\" style=\"text-align: center;vertical-align: middle\">\n            <strong>Lifeward Ltd. and subsidiaries<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" style=\"text-align: center;vertical-align: middle\">\n            <strong>Condensed Consolidated Balance Sheets<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(In thousands)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:76%;width:76%;min-width:76%;vertical-align: top\">\u00a0<\/td>\n<td style=\"max-width:12%;width:12%;min-width:12%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>(Unaudited)<\/strong>\n          <\/td>\n<td style=\"max-width:12%;width:12%;min-width:12%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>(Audited)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>September 30,<\/strong>\n          <\/td>\n<td style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>December 31,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Assets<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Current assets<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Cash and cash equivalents<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">$4,548<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">$2,169<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Restricted cash<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">3<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">240<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Clinical trial services asset<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">539<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Trade receivables, net of credit losses of $209 and $192, respectively<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">7,649<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">6,138<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:75%;min-width:75%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Prepaid expenses and other current assets<\/td>\n<td style=\"max-width:12%;min-width:12%;padding-left: 0;text-align: right;vertical-align: middle;vertical-align: top\">2,261<\/td>\n<td style=\"max-width:12%;min-width:12%;text-align: right;vertical-align: middle;vertical-align: top\">1,528<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Inventories<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">6,697<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">5,732<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Total current assets<\/td>\n<td style=\"padding-left: 0;text-align: right;vertical-align: middle;vertical-align: top\">21,697<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">15,807<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Restricted cash and other long term assets<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">484<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">209<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Clinical trial services asset<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">269<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Operating lease right-of-use assets<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">2,441<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,544<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Property and equipment, net<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">463<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">585<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Intangible assets<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">409<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Goodwill<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">4,755<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">4,755<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Total assets<\/td>\n<td style=\"border-bottom: double black 3pt;padding-left: 0;text-align: right;vertical-align: middle;vertical-align: top\">$30,518<\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">$22,900<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Liabilities and equity<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Current liabilities<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Trade payables<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">$5,838<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">$5,590<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Current maturities of operating leases<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">762<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">425<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Convertible promissory note<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">2,803<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Other current liabilities<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">4,255<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">3,221<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Total current liabilities<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">10,855<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">12,039<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Non-current operating leases<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,712<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,159<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Convertible promissory notes, net<\/td>\n<td style=\"padding-left: 0;text-align: right;vertical-align: middle;vertical-align: top\">7,133<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Warrants liability<\/td>\n<td style=\"padding-left: 0;text-align: right;vertical-align: middle;vertical-align: top\">1,988<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Other long-term liabilities<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,563<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,294<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Shareholders\u2019 equity<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">7,267<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">8,408<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Total liabilities and equity<\/td>\n<td style=\"border-bottom: double black 3pt;padding-left: 0;text-align: right;vertical-align: middle;vertical-align: top\">$30,518<\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">$22,900<\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"7\" style=\"width:427.893%;text-align: center;vertical-align: middle\">\n            <strong>Lifeward Ltd. and subsidiaries<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"7\" style=\"width:427.893%;text-align: center;vertical-align: middle\">\n            <strong>Condensed Consolidated Statements of Cash Flows<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"7\" style=\"width:427.893%;text-align: center;vertical-align: middle\">\n            <strong>(Unaudited)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"7\" style=\"width:427.893%;text-align: center;vertical-align: middle\">\n            <strong>(In thousands)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"7\" style=\"width:427.893%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:76.0582%;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"6\" style=\"width:351.835%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Nine Months Ended<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:76.0582%;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"6\" style=\"width:351.835%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:76.0582%;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"3\" style=\"width:163.955%;border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong>\n          <\/td>\n<td colspan=\"3\" style=\"width:187.88%;border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:76%;width:76.0582%;min-width:76%;vertical-align: top\">Net cash used in operating activities<\/td>\n<td colspan=\"2\" style=\"max-width:11%;width:162.977%;min-width:11%;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">$(16,064<\/td>\n<td style=\"max-width:1%;width:0.977892%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"max-width:11%;width:186.902%;min-width:11%;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">$(13,271<\/td>\n<td style=\"max-width:1%;width:0.977892%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:76.0582%;vertical-align: top\">Net cash used in investing activities<\/td>\n<td colspan=\"2\" style=\"width:162.977%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(28<\/td>\n<td style=\"width:0.977892%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"width:186.902%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(5<\/td>\n<td style=\"width:0.977892%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:76.0582%;vertical-align: top\">Net cash provided by financing activities<\/td>\n<td colspan=\"2\" style=\"width:162.977%;text-align: right;vertical-align: middle;vertical-align: top\">18,502<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.902%;text-align: right;vertical-align: middle;vertical-align: top\">8,425<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:76.0582%;vertical-align: top\">Effect of exchange rate changes on cash, cash equivalents and restricted cash<\/td>\n<td colspan=\"2\" style=\"width:162.977%;border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(9<\/td>\n<td style=\"width:0.977892%;border-bottom: solid black 1pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"width:186.902%;border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">103<\/td>\n<td style=\"width:0.977892%;border-bottom: solid black 1pt\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:76.0582%;vertical-align: top\">Increase (decrease) in cash, cash equivalents, and restricted cash<\/td>\n<td colspan=\"2\" style=\"width:162.977%;text-align: right;vertical-align: middle;vertical-align: top\">2,401<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.902%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(4,748<\/td>\n<td style=\"width:0.977892%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:76.0582%;vertical-align: top\">Cash, cash equivalents, and restricted cash at beginning of period<\/td>\n<td colspan=\"2\" style=\"width:162.977%;border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">2,579<\/td>\n<td style=\"width:0.977892%;border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.902%;border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">7,108<\/td>\n<td style=\"width:0.977892%;border-bottom: solid black 1pt\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:76.0582%;vertical-align: top\">Cash, cash equivalents, and restricted cash at end of period<\/td>\n<td colspan=\"2\" style=\"width:162.977%;border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">$4,980<\/td>\n<td style=\"width:0.977892%;border-bottom: double black 3pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.902%;border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">$2,360<\/td>\n<td style=\"width:0.977892%;border-bottom: double black 3pt\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"5\" style=\"text-align: center;vertical-align: middle\">\n            <strong>Lifeward Ltd. and subsidiaries<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(Unaudited)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(In thousand)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Three Months Ended<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Nine Months Ended<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>September 30,<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:52%;width:52%;min-width:52%;vertical-align: top\">\u00a0<\/td>\n<td style=\"max-width:12%;width:12%;min-width:12%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong>\n          <\/td>\n<td style=\"max-width:12%;width:12%;min-width:12%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong>\n          <\/td>\n<td style=\"max-width:12%;width:12%;min-width:12%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong>\n          <\/td>\n<td style=\"max-width:12%;width:12%;min-width:12%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Revenues based on customer\u2019s location:<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">United States<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">$3,270\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">$4,044\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">$9,692\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">$10,263\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Europe<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">613\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">627\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">2,370\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">2,100\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Germany<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,003\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">1,192\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">2,835\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">3,209\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Asia-Pacific<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">298\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">103\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">586\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">269\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Rest of the world<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">244\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">229\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">491\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">1,112\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Total revenues<\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">$5,428\u2007<\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">$6,195\u2007<\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">$15,974\u2007<\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">$16,953\u2007<\/td>\n<\/tr>\n<\/table>\n<p align=\"center\">\n        \n      <\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>Lifeward Ltd. and subsidiaries<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>Reconciliation of GAAP to Non-GAAP Financial Measures<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(Unaudited)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(In thousands)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\" style=\"width:659.474%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"6\" style=\"width:255.779%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Three Months Ended<\/strong>\n          <\/td>\n<td colspan=\"6\" style=\"width:351.704%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Nine Months Ended<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"6\" style=\"width:255.779%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>September 30,<\/strong>\n          <\/td>\n<td colspan=\"6\" style=\"width:351.704%;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: top\">\n            <em>Dollars in thousands, except per share data<\/em>\n          <\/td>\n<td colspan=\"3\" style=\"width:115.899%;border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong>\n          <\/td>\n<td colspan=\"3\" style=\"width:139.88%;border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong>\n          <\/td>\n<td colspan=\"3\" style=\"width:163.861%;border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong>\n          <\/td>\n<td colspan=\"3\" style=\"width:187.843%;border-bottom: solid black 1pt;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:52%;width:51.9912%;min-width:52%;vertical-align: top\">\n            <strong>GAAP net loss<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:11%;width:114.921%;min-width:11%;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(5,052<\/strong>\n          <\/td>\n<td style=\"max-width:1%;width:0.977892%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:11%;width:138.902%;min-width:11%;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(3,170<\/strong>\n          <\/td>\n<td style=\"max-width:1%;width:0.977892%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:11%;width:162.883%;min-width:11%;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(27,364<\/strong>\n          <\/td>\n<td style=\"max-width:1%;width:0.977892%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:11%;width:186.865%;min-width:11%;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(14,566<\/strong>\n          <\/td>\n<td style=\"max-width:1%;width:0.977892%;min-width:1%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: top\">\n            <em>Adjustments:<\/em>\n          <\/td>\n<td colspan=\"12\" style=\"width:607.483%;text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Amortization of intangible assets<\/td>\n<td colspan=\"2\" style=\"width:114.921%;text-align: right;vertical-align: middle;vertical-align: top\">23<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:138.902%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:162.883%;text-align: right;vertical-align: middle;vertical-align: top\">33<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.865%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Non-cash acquired in-process R&amp;D expense<\/td>\n<td colspan=\"2\" style=\"width:114.921%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:138.902%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:162.883%;text-align: right;vertical-align: middle;vertical-align: top\">4,947<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.865%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Oramed transaction-related expenses<\/td>\n<td colspan=\"2\" style=\"width:114.921%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:138.902%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:162.883%;text-align: right;vertical-align: middle;vertical-align: top\">619<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.865%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Other income related to the settlement of the post closing statement for the acquisition of AlterG<\/td>\n<td colspan=\"2\" style=\"width:114.921%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:138.902%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:162.883%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(142<\/td>\n<td style=\"width:0.977892%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<td colspan=\"2\" style=\"width:186.865%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Restructuring<\/td>\n<td colspan=\"2\" style=\"width:114.921%;text-align: right;vertical-align: middle;vertical-align: top\">300<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:138.902%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:162.883%;text-align: right;vertical-align: middle;vertical-align: top\">544<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.865%;text-align: right;vertical-align: middle;vertical-align: top\">700<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Remeasurement of earnout liability<\/td>\n<td colspan=\"2\" style=\"width:114.921%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:138.902%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:162.883%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.865%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(608<\/td>\n<td style=\"width:0.977892%;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Impairment charges<\/td>\n<td colspan=\"2\" style=\"width:114.921%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:138.902%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:162.883%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.865%;text-align: right;vertical-align: middle;vertical-align: top\">2,783<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Stock-based compensation expenses<\/td>\n<td colspan=\"2\" style=\"width:114.921%;text-align: right;vertical-align: middle;vertical-align: top\">103<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:138.902%;text-align: right;vertical-align: middle;vertical-align: top\">174<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:162.883%;text-align: right;vertical-align: middle;vertical-align: top\">542<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.865%;text-align: right;vertical-align: middle;vertical-align: top\">576<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Non-cash amortization of debt discount associated with the convertible notes and warrants<\/td>\n<td colspan=\"2\" style=\"width:114.921%;text-align: right;vertical-align: middle;vertical-align: top\">457<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:138.902%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:162.883%;text-align: right;vertical-align: middle;vertical-align: top\">1,415<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.865%;text-align: right;vertical-align: middle;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Fair value remeasurement of warrant and derivative liabilities<\/td>\n<td colspan=\"2\" style=\"width:114.921%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">(1,347<\/td>\n<td style=\"width:0.977892%;border-bottom: solid black 1pt\">)\u00a0<\/td>\n<td colspan=\"2\" style=\"width:138.902%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%;border-bottom: solid black 1pt\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:162.883%;padding-right: 0;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">5,041<\/td>\n<td style=\"width:0.977892%;padding-left: 0;text-align: left;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"width:186.865%;text-align: right;vertical-align: middle;border-bottom: solid black 1pt;vertical-align: top\">&#8211;<\/td>\n<td style=\"width:0.977892%;border-bottom: solid black 1pt\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: top\">\n            <strong>Non-GAAP net loss<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"width:114.921%;border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(5,516<\/strong>\n          <\/td>\n<td style=\"width:0.977892%;border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"width:138.902%;border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(2,996<\/strong>\n          <\/td>\n<td style=\"width:0.977892%;border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"width:162.883%;border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(14,365<\/strong>\n          <\/td>\n<td style=\"width:0.977892%;border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"width:186.865%;border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(11,115<\/strong>\n          <\/td>\n<td style=\"width:0.977892%;border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: top\">Weighted average shares used in computing net loss per share (*)<\/td>\n<td colspan=\"3\" style=\"width:115.899%;border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">3,836,950\u2007<\/td>\n<td colspan=\"3\" style=\"width:139.88%;border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">1,335,117\u2007<\/td>\n<td colspan=\"3\" style=\"width:163.861%;border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">2,760,466\u2007<\/td>\n<td colspan=\"3\" style=\"width:187.843%;border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">1,050,290\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"width:51.9912%;vertical-align: top\">\n            <strong>Non-GAAP net loss per share<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"width:114.921%;border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(1.44<\/strong>\n          <\/td>\n<td style=\"width:0.977892%;border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"width:138.902%;border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(2.24<\/strong>\n          <\/td>\n<td style=\"width:0.977892%;border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"width:162.883%;border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(5.20<\/strong>\n          <\/td>\n<td style=\"width:0.977892%;border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"width:186.865%;border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(10.58<\/strong>\n          <\/td>\n<td style=\"width:0.977892%;border-bottom: double black 3pt;padding-left: 0;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>)<\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        <em>(*) All share and per share amounts presented in this note have been retroactively adjusted to reflect the Company\u2019s 1-for-12 reverse share split effected on February 24, 2026.<\/em>\n      <\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>Lifeward Ltd. and subsidiaries<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>Reconciliation of GAAP to Non-GAAP Financial Measures<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(Unaudited)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(In thousands)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"13\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"6\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Three Months Ended September 30,<\/strong>\n          <\/td>\n<td colspan=\"6\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Nine Months Ended September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"3\" style=\"padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"3\" style=\"padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"3\" style=\"padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"3\" style=\"padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:36%;width:36%;min-width:36%;vertical-align: top\">\n            <em>Dollars in thousands<\/em>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:21%;min-width:21%;vertical-align: top\">\n            <strong>GAAP operating loss<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:10%;min-width:10%;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(5,970<\/strong><br \/>\n            <strong>)<\/strong><br \/>\n            \n          <\/td>\n<td style=\"max-width:10%;min-width:10%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>(110.0<\/strong><br \/>\n            <strong>)%<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"2\" style=\"max-width:10%;min-width:10%;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(3,140<\/strong><br \/>\n            <strong>)<\/strong>\n          <\/td>\n<td style=\"max-width:1%;min-width:1%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>(50.7<\/strong><br \/>\n            <strong>)%<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"2\" style=\"max-width:10%;min-width:10%;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(20,461<\/strong><br \/>\n            <strong>)<\/strong>\n          <\/td>\n<td style=\"max-width:1%;min-width:1%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>(128.1<\/strong><br \/>\n            <strong>)%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:10%;min-width:10%;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(14,556<\/strong><br \/>\n            <strong>)<\/strong>\n          <\/td>\n<td style=\"max-width:10%;min-width:10%;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>(85.9<\/strong><br \/>\n            <strong>)%<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Amortization of intangible assets<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">23\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">0.4%\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">33\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">0.2%\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Non-cash acquired in-process R&amp;D expense<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">4,947\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">31.0%\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Oramed transaction-related expenses<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">619\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">3.9%\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Other income related to the settlement of the post closing statement for the acquisition of AlterG<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <br \/>(142)<\/td>\n<td style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(0.9)%<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Restructuring<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">300\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">5.5%\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">544\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">3.4%\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">700\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">4.1%\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Remeasurement of earnout liability<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(608)<\/td>\n<td style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(3.6)%<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Impairment charges<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">2,783\u2007<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">16.4%\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Stock-based compensation expenses<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">103\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">1.9%\u2007<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">174\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">2.8%\u2007<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">542\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">3.4%\u2007<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">576\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">3.4%\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Non-GAAP operating loss<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(5,544<\/strong><br \/>\n            <strong>)<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>(102.2<\/strong><br \/>\n            <strong>)%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(2,966<\/strong><br \/>\n            <strong>)<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>(47.9<\/strong><br \/>\n            <strong>)%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(13,918<\/strong><br \/>\n            <strong>)<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>(87.1<\/strong><br \/>\n            <strong>)%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;padding-left: 0;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong><br \/>\n            <strong>(11,105<\/strong><br \/>\n            <strong>)<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>(65.6<\/strong><br \/>\n            <strong>)%<\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"4\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Three Months Ended September 30,<\/strong>\n          <\/td>\n<td colspan=\"4\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Nine Months Ended September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:36%;width:36%;min-width:36%;vertical-align: top\">\n            <em>Dollars in thousands<\/em>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>GAAP gross profit<\/strong>\n          <\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$1,487\u2007<\/strong>\n          <\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>27.4%\u2007<\/strong>\n          <\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$2,707\u2007<\/strong>\n          <\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>43.7%\u2007<\/strong>\n          <\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$5,538\u2007<\/strong>\n          <\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>34.7%\u2007<\/strong>\n          <\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$7,340\u2007<\/strong>\n          <\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>43.3%\u2007<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <em>Adjustments:<\/em>\n          <\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Stock-based compensation expenses<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">4\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">0.1%\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">3\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">0.0%\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">10\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">0.1%\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">10\u2007<\/td>\n<td style=\"border-bottom: solid black 1pt;text-align: right;vertical-align: middle;vertical-align: top\">0.1%\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Non-GAAP gross profit<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$1,491\u2007<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>27.5%\u2007<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$2,710\u2007<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>43.7%\u2007<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$5,548\u2007<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>34.8%\u2007<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$7,350\u2007<\/strong>\n          <\/td>\n<td style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>43.4%\u2007<\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"8\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Three Months Ended September 30,<\/strong>\n          <\/td>\n<td colspan=\"8\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Nine Months Ended September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"4\" style=\"padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"4\" style=\"padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"4\" style=\"padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"4\" style=\"padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:36%;width:36%;min-width:36%;vertical-align: top\">\n            <em>Dollars in thousands<\/em>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>GAAP research &amp; development<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$1,941\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>35.8%\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$721\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>11.6%\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$9,540\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>59.7%\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$2,406\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>14.2%\u2007<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <em>Adjustments:<\/em>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Amortization of intangible assets<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(23)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(0.4)%<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(33)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(0.2)%<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Non-cash acquired in-process R&amp;D expense<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(4,947)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(31.0)%<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Stock-based compensation expenses<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(30)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(0.6)%<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(32)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(0.5)%<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(104)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(0.7)%<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(105)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(0.6)%<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Non-GAAP research &amp; development<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$1,888\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>34.8%\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$689\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>11.1%\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$4,456\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>27.8%\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$2,301\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>13.6%\u2007<\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"center\">\n        \n      <\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"17\" style=\"text-align: center;vertical-align: middle\">\n            <strong>Lifeward Ltd. and subsidiaries<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"17\" style=\"text-align: center;vertical-align: middle\">\n            <strong>Reconciliation of GAAP to Non-GAAP Financial Measures<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"17\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(Unaudited)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"17\" style=\"text-align: center;vertical-align: middle\">\n            <strong>(In thousands)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"17\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"8\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Three Months Ended September 30,<\/strong>\n          <\/td>\n<td colspan=\"8\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Nine Months Ended September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"4\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"4\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"4\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"4\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:36%;width:36%;min-width:36%;vertical-align: top\">\n            <em>Dollars in thousands<\/em>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>GAAP sales &amp; marketing<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$3,351<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>61.7%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$3,168<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>51.1%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$10,153<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>63.6%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$10,790<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>63.6%<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <em>Adjustments:<\/em>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Restructuring<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(244)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(1.5)%<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(277)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(1.6)%<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Stock-based compensation expenses<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(36)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(0.7)%<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(65)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(1.0)%<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(99)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(0.6)%<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(203)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(1.2)%<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Non-GAAP sales &amp; marketing<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$3,315<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>61.0%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$3,103<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>50.1%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$9,810<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>61.5%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$10,310<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>60.8%<\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table align=\"center\" style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<td colspan=\"8\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Three Months Ended September 30,<\/strong>\n          <\/td>\n<td colspan=\"8\" style=\"text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>Nine Months Ended September 30,<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:36%;min-width:36%;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"4\" style=\"max-width:8%;min-width:8%;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"4\" style=\"max-width:8%;min-width:8%;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"4\" style=\"max-width:8%;min-width:8%;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2026<\/strong><br \/>\n            \n          <\/td>\n<td colspan=\"4\" style=\"max-width:8%;min-width:8%;padding-right: 0;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>2025<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:36%;width:36%;min-width:36%;vertical-align: top\">\n            <em>Dollars in thousands<\/em>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>$<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"max-width:8%;width:8%;min-width:8%;border-bottom: solid black 1pt;text-align: center;vertical-align: middle;vertical-align: top\">\n            <strong>% of revenue<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>GAAP general &amp; administrative<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$2,165<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>39.9%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$1,958<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>31.6%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$6,306<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>39.5%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$5,917<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>34.9%<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <em>Adjustments:<\/em>\n          <\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Other income related to the settlement of the post closing statement for the acquisition of AlterG<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">142\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">0.9\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Oramed transaction-related expenses<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(619)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(3.9)%<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Restructuring<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(300)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(5.5)%<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(300)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(1.9)%<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(423)<\/td>\n<td colspan=\"2\" style=\"padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(2.5)%<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Remeasurement of earnout liability<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">-\u2007<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">608<\/td>\n<td colspan=\"2\" style=\"text-align: right;vertical-align: middle;vertical-align: top\">3.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 15.0px;vertical-align: top\">Stock-based compensation expenses<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(33)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(0.6)%<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(74)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(1.2)%<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(329)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(2.1)%<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(258)<\/td>\n<td colspan=\"2\" style=\"border-bottom: solid black 1pt;padding-right: 0;text-align: right;vertical-align: middle;vertical-align: top\">(1.5)%<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Non-GAAP general &amp; administrative<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$1,832<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>33.8%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$1,884\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>30.4%\u2007<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$5,200<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>32.5%<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>$5,844<\/strong>\n          <\/td>\n<td colspan=\"2\" style=\"border-bottom: double black 3pt;text-align: right;vertical-align: middle;vertical-align: top\">\n            <strong>34.5%<\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzllNzZmNzctOWYxZC00MjYzLTk2N2UtYTY0ODNjY2FjZTI2LTEwMjI3NTYtMjAyNi0xMS0xMy1lbg==\/tiny\/Lifeward-Ltd-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AlterG revenue increased 18% year-over-year to $3.6 million, driven by higher U.S. unit shipments, service revenue and average selling prices The Company is advancing its transition of ReWalk to a capital-efficient channel-partner distribution model designed to expand patient access and support long-term revenue growth New leadership team focused on commercial execution and advancing AI-enabled rehabilitation technologies New peer-reviewed clinical evidence strengthens support for ReWalk\u2019s long-term benefits and broader patient access HUDSON, Mass. and YOKNEAM ILLIT, Israel, Nov. 13, 2026 (GLOBE NEWSWIRE) &#8212; Lifeward Ltd. (Nasdaq: LFWD) (\u201cLifeward\u201d or the \u201cCompany\u201d), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today reported financial results for the third quarter ended September 30, 2026, and provided &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1020956","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AlterG revenue increased 18% year-over-year to $3.6 million, driven by higher U.S. unit shipments, service revenue and average selling prices The Company is advancing its transition of ReWalk to a capital-efficient channel-partner distribution model designed to expand patient access and support long-term revenue growth New leadership team focused on commercial execution and advancing AI-enabled rehabilitation technologies New peer-reviewed clinical evidence strengthens support for ReWalk\u2019s long-term benefits and broader patient access HUDSON, Mass. and YOKNEAM ILLIT, Israel, Nov. 13, 2026 (GLOBE NEWSWIRE) &#8212; Lifeward Ltd. (Nasdaq: LFWD) (\u201cLifeward\u201d or the \u201cCompany\u201d), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today reported financial results for the third quarter ended September 30, 2026, and provided &hellip; Continue reading &quot;Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-13T14:29:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update\",\"datePublished\":\"2026-11-13T14:29:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/\"},\"wordCount\":2768,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/\",\"name\":\"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM=\",\"datePublished\":\"2026-11-13T14:29:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/","og_locale":"en_US","og_type":"article","og_title":"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update - Market Newsdesk","og_description":"AlterG revenue increased 18% year-over-year to $3.6 million, driven by higher U.S. unit shipments, service revenue and average selling prices The Company is advancing its transition of ReWalk to a capital-efficient channel-partner distribution model designed to expand patient access and support long-term revenue growth New leadership team focused on commercial execution and advancing AI-enabled rehabilitation technologies New peer-reviewed clinical evidence strengthens support for ReWalk\u2019s long-term benefits and broader patient access HUDSON, Mass. and YOKNEAM ILLIT, Israel, Nov. 13, 2026 (GLOBE NEWSWIRE) &#8212; Lifeward Ltd. (Nasdaq: LFWD) (\u201cLifeward\u201d or the \u201cCompany\u201d), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today reported financial results for the third quarter ended September 30, 2026, and provided &hellip; Continue reading \"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-13T14:29:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update","datePublished":"2026-11-13T14:29:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/"},"wordCount":2768,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/","name":"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM=","datePublished":"2026-11-13T14:29:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NzIyOSM3OTY0NjY0IzIwMTExODM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifeward-reports-third-quarter-2026-financial-results-and-provides-business-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1020956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1020956"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1020956\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1020956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1020956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1020956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}